Author Topic: New inroads against MS [JAMA interview with Dr. Stephen Hauser and Dr. Jeffrey Cohen]  (Read 130 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9817
  • MS diagnosed 1980
  • Location: Pacific Northwest
JAMA interview (December 13, 2017) with Dr. Stephen Hauser and Dr. Jeffrey A. Cohen. Stephen Hauser, MD, of the University of California, San Francisco, led the development of ocrelizumab, and Jeffrey A. Cohen, MD, of the Cleveland Clinic,  has been pursuing research into remyelination.

The focus of the discussion is on Ocrevus:

https://jamanetwork.com/journals/jama/fullarticle/2666528
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
94 Views
Last post November 15, 2016, 04:25:12 pm
by agate
0 Replies
135 Views
Last post March 20, 2017, 07:41:32 pm
by agate
0 Replies
93 Views
Last post December 14, 2017, 04:28:42 pm
by agate
1 Replies
123 Views
Last post May 01, 2021, 09:36:11 pm
by agate
0 Replies
11 Views
Last post January 04, 2024, 09:27:56 pm
by agate